Cell cycle G2/M arrest and activation of cyclin-dependent kinases associated with low-dose paclitaxel-induced sub-G1 apoptosis

Apoptosis

Volumn 2, Issue 5, 1997, Pages 463-470

  Shu, C H ^a   Yang, W K ^c   Shih, Y L ^c   Kuo, M L ^b   Huang, T S ^c,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; CDC 2 (CDK 1); CDK 7; Cyclin B1; G2 M arrest; Paclitaxel (Taxol )

Indexed keywords

EID: 0001444371     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026422111457     Document Type: Article

References (49)

1. McGuire WP, Rowinsky EK, Rosenshein NB, et al. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989; 111: 273-279.
2. Holmes FA, Walters RS, Theriault RL, et al Phase II trial of Taxol: An active drug in the treatment of metastatic breast cancer. JNCI 1991; 83: 1797-1805.
3. Forastiere AA, Neuberg D, Taylor IV SG, Deconti R, Adams G. Phase II evaluation of Taxol in advanced head and neck cancer: An Eastern Cooperative Oncology Group Trial. Monogr Natl Cancer Inst 1993; 15: 181-184.
4. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME, Huang Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 1993; 7: 563-568.
5. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Brit J Cancer 1993; 68: 1104-1109.
6. Liu Y, Bhalla K, Hill C, Priest DG. Evidence for involvement of tyrosine phophorylation in taxol-induced apoptosis in a human ovairan tumor cell line. Biochem Pharmacol 1994; 48: 1265-1272.
7. BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia 1995; 8: 1960-1969.
8. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980; 77: 1561-1565.
9. Crossin KL, Carney DH. Mcrotubule stabilization by taxol inhibits initiation of DNA synthesis by thrombin and epidermal growth factor. Cell 1981; 27: 341-350.
10. Jordan MA, Toso RJ, Thrower D, Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 1993; 90: 9552-9556.
11. Lopes NM, Adams EG, Pitts TW, Bhuyan BK. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 1993; 32: 235-242.
12. Ireland CM, Pittman SM. Tubulin alterations in taxol-induced apoptosis parallel those observed with other drugs. Biochem Pharmacol 1995; 49: 1491-1499.
13. Seiter K, Feldman EJ, Traganos F, et al. Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study with paclitaxel. Leukemia 1995; 9: 1961-1966.
14. Halicka HD, Seiter K, Feldman EJ, et al. Cell cycle specificity of apoptosis during treatment of leukemias. Apoptosis 1997; 2: 25-39.
15. cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ 1994; 5: 1041-1050.
16. Donaldson KL, Goolsby G, Wahl AF. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Eur J Cancer 1994; 57: 847-855.
17. +. Cell 1987; 50: 319-325.
18. Arion D, Meijer L, Brizuela L, Beach D. cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF. Cell 1988; 55: 371-378.
19. cdc2. Cell 1989; 58: 833-846.
20. Doree M. Control of M-phase by maturation promoting factor. Curr Opin Cell Biol 1990; 2: 269-273.
21. Gautier J, Minshull J, Lohka M, Glotzer M, Hunt T, Maller JL. Cyclin is a component of a maturation-promoting factor from Xenopus. Cell 1990; 60: 487-494.
22. Walker DH, Maller JL. Role of the cyclin A in the dependence of mitosis on completion of DNA replication Nature 1991; 345: 314-317.
23. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J 1992; 11: 961-971.
24. Devault A, Martinez AM, Fesquet D, et al. MAT1 a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK. EMBO J 1995; 14: 5027-5036.
25. Fisher RP, Jin P, Chamberlin HM, Morgan DO. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 1995; 83: 47-57.
26. Tassan JP, Jaquenoud M, Fry AM, Frutiger S, Hughes GJ, Nigg EA. In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J 1995; 14: 5608-5617.
27. 2. Proc Natl Acad Sci USA 1990; 87: 5139-5143.
28. cdc2. Cell 1991; 67: 197-211.
29. cdc2 kinase activation in vertebrates. EMBO J 1991; 10: 3331-3341.
30. Meikrantz W, Gisselbrecht S, Tam SW, Schlegel R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci USA 1994; 91: 3754-3758.
31. Hoang AT, Cohen KJ, Barrett JF, Bergstrom DA, Dang CV. Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci USA 1994; 91: 6875-6879.
32. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995; 268: 429-431.
33. cdc2 activation required for apoptosis. Science 1994; 263: 1143-1145.
34. Shimizu T, O'Connor PM, Kohn KW, Pommier Y. Unscheduled activation of Cyclin B1/Cdc 2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res 1995; 55: 228-231.
35. Fotedar R, Flatt J, Gupta S, et al. Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. Mol Cell Biol 1995; 15: 932-942.
36. Huang T-S, Shu C-H, Yang WK, Whang-Peng J. Activation of CDC 25 phosphatase and CDC 2 kinase involved in GL331-induced apoptosis. Cancer Res 1997; in press.
37. Shu C-H, Yang WK, Huang T-S. Increased cyclin B1/CDC 2 kinase activity and phosphorylation of Bcl-2 associated with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis 1996; 1: 141-146.
38. Lin CT, Chan WY, Chen W, et al. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 1993; 68: 716-727.
39. 1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.Oncogene 1996; 13: 625-632.
40. Yuan C-C, Huang H-C, Tsai L-C, Ng H-T, Huang T-S. Cytokeratin-19 associated with apoptosis and chemosensitivity in human cervical cancer cells. Apoptosis 1997; 2: 101-105.
41. 1 pathways. Proc Natl Acad Sci USA. 1995; 92: 4793-4797.
42. Huang T-S, Yang WK, Whang-Peng J. GL331-induced disruption of cyclin B1/CDC 2 complex and inhibition of CDC 2 kinase activity Apoptosis 1996; 1: 213-217.
43. Martin SJ, Green DR, Cotter TG. Dicing with death: dissecting the components of the apoptosis machinery Trends Biochem Sci 1994; 19: 26-30.
44. Nurse, P. Ordering S phase and M phase in the cell cycle. Cell 1994; 79: 547-550.
45. King RW, Jackson PK, Kirschner MW. Mtosis in transition. Cell 1994; 79: 563-571.
46. Dunphy WG, Newport JW. Unraveling of mitotic control mechanisms. Cell 1988; 55: 925-928.
47. Lazebnik YA, Takahashi A, Moir RD, et al. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 1995; 92: 9042-9046.
48. Kayalar C, Ord T, Testa MP, Zhong L-T, Bredesen DE. Cleavage of actin by interleukin 1β-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci USA 1996; 93: 2234-2238.
49. Dou QP. Putative roles of retinoblastoma protein in apoptosis. Apoptosis 1997; 2: 5-18.